Refine Results
- 必威体育赛事投注
- Content Type
- Analysis Platform
- Language
- Publication Date
41 - 60 of 74 results
Applied Filters
必威体育登录手机Using the Agilent xCELLigence RTCA eSight to continuously monitor CAR T cell-mediatedkilling of cancer cells over the course of multiplae days.
| Chinese (Simplified) (China) | Complete (PDF) |
|---|
必威体育登录手机A 16-color T cell immunophenotyping panel was developed for the Agilent NovoCyte Advanteon to simultaneously analyze T cell differentiation, activation, exhaustion, and functional output through degranulation and cytokine expression
| German (Germany) | Complete (PDF) |
|---|---|
| Russian (Russia) | Complete (PDF) |
| Chinese (Simplified) (China) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
| Italian (Italy) | Complete (PDF) |
| French (France) | Complete (PDF) |
Two workflows using MitoXpress Xtra and pH-Xtra probes to investigate cell metabolism in intact RAFT 3D collagen structures on fluorescent plate readers.
NovoCyte Advanteon Brochure
| German (Germany) | Complete (PDF) |
|---|---|
| Italian (Italy) | Complete (PDF) |
| Chinese (Simplified) (China) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
| French (France) | Complete (PDF) |
必威体育登录手机Using the Agilent xCELLigence RTCA system to assess both the selectivity and potency of the TCR-engineered TILs toward HLA restricted cells.
Examines the phosphorylation of signal transducer and activator of transcription (STAT) proteins in response to cytokine stimulation using a phosphoflow technique.
Overview of the SureSelect Cancer All-In-One workflow
必威体育登录手机Measuring bioenergetic phenotype, cellular ATP production rates, and mitochondrial and glycolytic function with Agilent Seahorse XF technology can reveal metabolic vulnerabilities in cancer cells to advance cancer therapeutics.
| Russian (Russia) | Complete (PDF) |
|---|---|
| Italian (Italy) | Complete (PDF) |
| French (France) | Complete (PDF) |
| Spanish (Spain) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
| Chinese (Simplified) (China) | Complete (PDF) |
必威体育登录手机Supplemental procedures to perform XF assays in hypoxia chambers using the Agilent Seahorse XF Analyzer.
必威体育登录手机Identifying Metabolic Phenotype Switches in Cancer Cells Using the Agilent Seahorse XF/XFe Analyzer in an Hypoxic Environment
必威体育登录手机This flyer provides and overview of the family of Agilent SureSelect Community Designs designed by scientists in the Adam's Group at the Wellcome Sanger Institute.The aim of the research is to understand the genetics of cancer, using a combination...
必威体育登录手机Customize insights for tumor genomic profiling by adding new and emerging biomarkers, including TMB and MSI, with Agilent SureSelect Cancer Custom panels.必威体育登录手机Fast and easy panel design with Agilent SureDesign.
PD-L1 IHC 22C3 pharmDx (SK006) is a qualitative immunohistochemical (IHC) assay using anti-PD-L1, Clone 22C3, to detect PD-L1 in formalin-fixed, paraffin-embedded (FFPE) tumor tissues using the Autostainer Link 48.
This study investigates the impact of Wnt-signaling modulators on mitochondrial dysfunction.It evaluates the effects of selected drug treatments on cellular energy metabolism and cytotoxicity by comparing two distinct breast cancer cell lines: one...
This poster outlines combining the 3D tumor spheroid invasion model with the RTCA eSight's capability of live cell imaging and automatic quantification of the area of invasive protrusion can facilitate and enhance the development of new treatments...
In the present study, we present a simple metabolic preconditioning process that improves T-cell performance and bioenergetics.
Case study about cancer nutrient pathways and Seahorse-metabolomics synergies
We connected with cancer research experts from around the world to understand how the evolution of today's lab has benefited their efforts and expectations for the future.